This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jan 1;38(1):105-106.

doi: 10.1200/JCO.19.01728. Epub 2019 Nov 1.

Immortal Time Bias Question in the Association Between Toxicity and Outcome of Immune Checkpoint Inhibitors

Filippo G Dall'Olio¹, Vincenzo Di Nunno¹, Francesco Massari¹

Affiliations

PMID: 31675246
DOI: 10.1200/JCO.19.01728

Comment

Immortal Time Bias Question in the Association Between Toxicity and Outcome of Immune Checkpoint Inhibitors

Filippo G Dall'Olio et al. J Clin Oncol. 2020.

. 2020 Jan 1;38(1):105-106.

doi: 10.1200/JCO.19.01728. Epub 2019 Nov 1.

Authors

Filippo G Dall'Olio¹, Vincenzo Di Nunno¹, Francesco Massari¹

Affiliation

¹ Filippo G. Dall'Olio, MD; Vincenzo Di Nunno, MD; and Francesco Massari, MD, Policlinico Sant'Orsola Malpighi, Bologna, Italy.

PMID: 31675246
DOI: 10.1200/JCO.19.01728

No abstract available

PubMed Disclaimer

Comment on

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody.
Maher VE, Fernandes LL, Weinstock C, Tang S, Agarwal S, Brave M, Ning YM, Singh H, Suzman D, Xu J, Goldberg KB, Sridhara R, Ibrahim A, Theoret M, Beaver JA, Pazdur R. Maher VE, et al. J Clin Oncol. 2019 Oct 20;37(30):2730-2737. doi: 10.1200/JCO.19.00318. Epub 2019 May 22. J Clin Oncol. 2019. PMID: 31116675

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.